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49 Abstract 
 
50 We  have  identified  and  characterized  a  spontaneous  Brown  Norway  rat  strain  (BN-J) 
 
51 presenting  a  progressive  retinal  degeneration  associated  with  early  retinal  telangiectasia, 
 
52 neuronal  alterations,  and  loss  of  retinal  Müller  glial  cells,  resembling  human  macular 
 
53 telangiectasia type 2  (MacTel 2), which is a  retinal disease of unknown cause.  Genetic 
 
54 analyses showed that the BN-J phenotype results from an autosomal recessive indel  novel 
 
55 mutation in the Crb1 gene, causing dislocalization of the protein from the retinal Müller glia 
 
56 (RMG)/photoreceptor cell junction. The transcriptomic analyses of primary RMG  cultures 
 
57 allowed identification of the dysregulated pathways in BN-J rats as compared to wild-type BN 
 
58 rats. Among those pathways, TGF Beta and Kit Receptor Signaling, MAPK Cascade, Growth 
 
59 factors  and  Inflammatory Pathways,  G  Protein  Signaling  Pathways,  Regulation  of  Actin 
 
60 Cytoskeleton and Cardiovascular Signaling were found. Potential molecular targets  linking 
 
61 RMG/photoreceptor interaction with the development of retinal telangiectasia are identified. 
 
62 This model can serve to better understand the physiopathologic mechanisms of MacTel 2 and 
 
63 other retinal diseases associated with telangiectasia. 
64 
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65 Introduction 
 
66 Retinal Müller glial cells (RMG) span the entire thickness of the retina and establish 
 
67 links  between  retinal  blood  vessels  and  photoreceptors,  providing  nutritional  support, 
 
68 removing metabolic waste and maintaining homeostasis of extracellular medium (Bringmann 
 
69 et al., 2006). RMG cells intervene in the formation and maintenance of the inner blood-retinal 
 
70 barrier (Tout et al., 1993; Tretiach et al., 2005) and connect to photoreceptors with adherens 
 
71 and tight-like junctions at the outer limiting membrane (OLM) (Omri et al., 2012). It was 
 
72 recently suggested that RMG cells may play a role in the development of diabetic retinopathy 
 
73 (Fletcher et al., 2005; Bringmann et al., 2006) and macular telangiectasia type 2 (MacTel 2) 
 
74 (Powner et al., 2010). 
 
75 MacTel 2  is  a progressive retinal disease characterized by vascular abnormalities, 
 
76 depletion  of  macular  luteal  pigment,  cystic  cavities  with  focal  disorganization  of  retinal 
 
77 lamination  (Yannuzzi  et  al.,  2006).  Photoreceptor  degeneration  is  associated  with  visual 
 
78 impairment (Ooto et al., 2011). In vivo optical coherence tomography further showed OLM 
 
79 defects associated with photoreceptor disruption (Zhu et al., 2013). Loss of RMG markers and 
 
80 reduction of RMG-associated proteins in the macula have been revealed on MacTel 2 retinas, 
 
81 providing evidences on the role of RMG in the disease pathogenesis (Powner et al., 2010; Len 
 
82 et al., 2012). 
 
83 During retinal development, RMG are required for photoreceptors outer segments 
 
84 assembly (Jablonski and Iannaccone, 2000; Wang et al., 2005) and in the post natal period, 
 
85 genetic RMG destruction led to retinal dysplasia and retinal degeneration (Dubois-Dauphin et 
 
86 al., 2000). On the other hand, RMG proliferation in mice lacking the cell cycle inhibitor 
 
87 protein p27Kip1 also induced retinal dysplasia, OLM disruption and leaky vascular dilation 
 
88 (Dyer and Cepko, 2000). 
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89 The  Crumbs  (CRB)  proteins,  particularly CRB1,  located  in  the  sub-apical  region 
 
90 above  the  OLM,  form  a  molecular  scaffold  with  Pals1  and  Patj,  and  interact  with  the 
 
91 Par6/Par3/aPKC  complex  and  with  β-catenin  (Alves  et  al.,  2014).  CRB1,  expressed  in 
 
92 mammalian RMG cells, is essential for OLM formation and for photoreceptor morphogenesis 
 
93 (Mehalow et al., 2003; van de Pavert et al., 2004). Interestingly, crb1 mutations lead to retinal 
 
94 degenerations, potentially associated with coats-like vascular telangiectasia (den Hollander et 
 
95 al., 2004; Henderson et al., 2011). 
 
96 This report describes a BN rat strain (BN-J) that spontaneously develops progressive 
 
97 focal  retinal  layer disorganization,  loss  of  photoreceptors,  cystic  cavitation  and  RMG 
 
98 abnormalities associated with early retinal vascular telangiectasia and late stage sub-retinal 
 
99 neovascularization.  This  phenotype  bears  marked  resemblance  to  the  telangiectasia-like 
 
100 model obtained by specific RMG depletion (Shen et al., 2012) and   reminiscent of human 
 
101 MacTel 2 (Charbel Issa et al., 2012). A new mutation in exon 6 of the rat crb1 was identified 
 
102 to be responsible for this retinal phenotype. In addition, the full profile of genes differentially 
 
103 expressed in RMG cells extracted from the Crb1 mutated BN rat retina as compared to two 
 
104 wild-type strains, allowing identification of possible molecular targets. This data links CRB1- 
 
105 associated functions with rat retinal telangiectasia and possibly with human MacTel 2. 
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106 Materials and methods 
 
107 Animals 
 
108 All  experiments  were  performed  in  accordance  with  the  European  Communities 
 
109 Council Directive 86/609/EEC and approved by local ethical committees. Brown Norway rats 
 
110 obtained from Janvier Breeding Center (pathological BN-J rat, Le Genest-Saint-Isle, France) 
 
111 or Harlan Laboratories (wild-type BN-H rat, Gannat, France) and Lewis rats from Janvier 
 
112 Breeding Center were used. Rats of either sex were used. Animals were kept in pathogen-free 
 
113 conditions with food, water and litter and housed in a 12-hour light / 12-hour dark cycle.  For 
 
114 genetic analyses, four couples of pure parental strains (BN-H x BN-J) were cross-bred, which 
 
115 resulted in an F1. Four F1 couples were then cross-bred to produce an F2. Anesthesia was 
 
116 induced  by  intramuscular  ketamine  (40mg/kg)  and  xylazine  (4mg/kg).  Animals  were 
 
117 sacrificed by carbon dioxide inhalation. 
 
118 Fluorescein angiography 
 
119 BN-H and BN-J rats of different ages (8-week and 6-month old, n = 6 rats per time 
 
120 point) were used. Fluorescein (0.1 mL of 10% fluorescein in saline) was injected in the tail 
 
121 vein of anaesthetized rats. In vivo angiography was performed with a confocal scanning laser 
 
122 ophthalmoscope (cSLO, HRA, Heidelberg Engineering, Dossenheim, Germany). Images were 
 
123 collected at early and late time-points. 
 
124 Electroretinogram 
 
125 Electroretinographic (ERG) analyses were performed on 3-week old BN-H and BN-J 
 
126 rats  (n=4-5  per  strain)  using  VisioSystem  device  (Siem  Biomedicale,  Nimes,  France). 
 
127 
 
128 
Animals were dark-adapted overnight. Scotopic ERG was performed in the dark with light 
intensities of flashes ranging from 0.0003 to 10 cd.s/m2. For each intensity, the average 
129 response to 5 flashes at a frequency of 0.5 Hz was recorded.  Basic overall retinal responses 
 
130 were recorded following flashes at 0 dB intensity during 40 ms, at a frequency of 0.5 Hz. Five 
7  
131 
 
132 
 
133 
responses were averaged. For photopic recordings, animals were light-adapted for 10 min 
with a background light of 25 cd/m2, and then the response following a single light flash of 10 
cd.s/m2 was recorded. 
134 Histology 
 
135 BN-J and BN-H rats were sacrificed (adults at 8-week and 6-month old, n=4 rats per 
 
136 time point per strain, and postnatal day 1 (PN1), day 8 (PN8) and day 15 (PN15), n=3 per 
 
137 time point and per strain), and eyes enucleated for histological analyses using historesine 
 
138 sections (5 µm) stained with toluidine blue as previously described (Zhao et al., 2012). 
 
139 Semithin and ultrathin sections 
 
140 Eyes from BN rats (8-week and 6-month, n=4 rats per time point and per strain) were 
 
141 fixed  in  2.5%  glutaraldehyde  in  cacodylate  buffer  (0.1  mol/L,  pH7.4),  then  dissected, 
 
142 postfixed in 1% osmium tetroxide in cacodylate buffer and dehydrated in a graded series of 
 
143 alcohol before being included in epoxy resin. Semithin sections (1 µm) were stained with 
 
144 toluidine blue. Ultrathin sections (80 nm) were contrasted by uranyl acetate and lead citrate 
 
145 and observed with a transmission electron microscope and photographed. 
 
146 Retinal flat-mounts 
 
147 BN-H and BN-J  rats at 8 weeks were sacrificed (n=10  rats per strain). Rat flat- 
 
148 mounted retinas were prepared as previously described (Zhao et al., 2010). The following 
 
149 primary antibodies were used: rabbit anti-glial fibrillary acidic protein (GFAP, 1:100, Dako, 
 
150 Trappes, France), rabbit anti-glutamine synthetase (GS, 1:100, Sigma-Aldrich, Saint Quentin 
 
151 Fallavier, France), and secondary antibody Alexa Fluor 594-conjugated goat anti-rabbit IgG 
 
152 (1:100,  Molecular  Probes,  Leiden,  Netherlands).  Blood  vessels  were  stained  with  FITC- 
 
153 labeled  lectin  from  Bandeiraea  Simplicifolia  (1:100,  Sigma-Aldrich).  Images  were  taken 
 
154 using a confocal laser scanning microscope Zeiss LSM 710 (Oberkochen, Germany) and 
 
155 
 
156 
analyzed using Image J. 
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157 Immunohistochemistry on cryosections 
 
158 Eyes of 8-week old BN rats (n= 4 rats per strain) were used for cryosections. Cryostat 
 
159 sections were incubated with the following primary antibodies: mouse anti-CD31 (1:100, BD 
 
160 pharmingen, Le Pont de Claix, France), rabbit anti-GFAP (1:200), rabbit anti-GS (1:200), 
 
161 rabbit anti-cone arrestin (1:100, Millipore, Saint Quentin en Yvelines, France), mouse anti- 
 
162 rhodopsin (Rho4D2, 1:100, Abcam, Cambridge, UK), mouse anti-protein kinase C-alpha 
 
163 (PKC-α, 1:400, Santa Cruz, Heidelberg, Germany), rabbit anti-synaptophysin (1:200, Abcam), 
 
164 rabbit anti-CRB1 (AK2, 1:150) (van de Pavert et al., 2004), and secondary antibodies: Alexa 
 
165 Fluor 488- or 594- conjugated goat anti-mouse IgG (1:200, Molecular Probes) and   Alexa 
 
166 Fluor  488-  or  594-conjugated  goat  anti-rabbit  IgG  (1:200,  Molecular  Probes).  Cone 
 
167 photoreceptor segments were labeled with FITC-conjugated peanut agglutinin (PNA, 1:100, 
 
168 Sigma-Aldrich).  Cell  nuclei  were  stained  with  4’,6-Diamidino-2-Phenyl-Indole  (DAPI, 
 
169 1:3000,  Sigma-Aldrich).  Negative  controls  were  performed  without  primary  antibodies. 
 
170 Images were taken using a fluorescence microscope (Olympus BX51, Rungis, France). 
 
171 In a separate experiment, using 5 animals per strain, retinal sections at the level of the 
 
172 optic nerve head were obtained. RMG cells were stained using rabbit anti-GS as well as rabbit 
 
173 anti-cellular retinaldehyde-binding protein (CRALBP, 1:250, kind gift from Dr John Saari, 
 
174 University of Washington, Seattle, WA), both RMG markers. RMG processes in the inner 
 
175 plexiform layer were counted on the entire retinal section. In addition, RMG cells were also 
 
176 counted using p27kip1 (1:100, Abcam), a RMG nuclear marker (Dyer and Cepko, 2000). 
 
177 Cone-arrestin positive cells (cones) were also counted. Using ImageJ, rhodopsin positive 
 
178 areas of rod outer segments were analyzed. 
 
179 Statistics 
9  
180 Experimental results were analyzed by Mann-Whitney U test using the Graph Prism5 
 
181 program. A P value of 0.05 or less was considered statistically significant. Data are presented 
 
182 graphically in figures as mean ± SE. 
 
183 Retinal Müller Cell Primary Culture 
 
184 RMG primary cultures were obtained from 3 consecutive PN 17 litters for each BN-H, 
 
185 BN-J and Lewis rat strain. Animals were sacrificed and eyes were enucleated. RMG cells 
 
186 were isolated as described (Zhao et al., 2010). 
 
187 RNA-sequencing and data analysis 
 
188 Total RNA was extracted from primary RMG cells of the 3 rat strains (n=3 samples 
 
189 per strain) using RNeasy Mini Kit (Qiagen, Courtaboeuf, France) including DNase I (Qiagen) 
 
190 treatment. RNA integrity was checked on the Agilent 2100 Bioanalyzer. RNA sequencing 
 
191 was performed on Illumina HiSeq 2000 platform according to the manufacturer's instructions. 
 
192 The average number of reads per sample was 27M. Reads from each sample were processed 
 
193 as follows. First, reads were trimmed using an in-house Perl script with a minimum phred- 
 
194 quality of 20 per-base and a minimum read length of 30bp. On average 24% of reads per 
 
195 sample  were  discarded.  The  resulting  reads  were  later  aligned  to  the  Rattus  norvegicus 
 
196 genome assembly 3.4 (from Ensembl), using  Tophat (Trapnell et al., 2009). Differential 
 
197 expression between BN-J and Lewis, BN-J and BN-H, BN-H and Lewis was calculated using 
 
198 the Cuffdiff program from the Cufflinks suite (Trapnell et al., 2010). Fold Changes >1.5 and 
 
199 FDR-corrected P values <0.05 were used as filters. The corresponding comparisons will be 
 
200 further reported as JL, JH and HL respectively. 
 
201 Signaling pathways for Rattus norvegicus were retrieved from WikiPathways (Kelder et 
 
202 al., 2012). Pathways with FDR-corrected P-values <0.05 were selected as enriched. Pathvisio 
 
203 2 (van Iersel et al., 2008) was used to visualize the pathways and map the values from each 
 
204 protein set. 
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205 Genetic analyses 
 
206 DNA was extracted from rats’ tails by Proteinase K (0.5 mg/ml; Sigma # P-2308) 
 
207 digestion  overnight  at  56°C  in  Lysis  Buffer  (50mM  Tris-Hcl  pH  8.0-  100mM  EDTA  - 
 
208 100mM NaCl - 1% SDS) then purified with the DNAzol kit (MRC #DN127) according to the 
 
209 manufacturer's  protocol.  Genomic DNA was then used as a template  for PCR reactions 
 
210 targeting coding exons of the crb1 gene using 35 cycles (94°C 2min; 59°C 30 sec; 72°C 30 
 
211 sec).  PCR  products  were  subsequently  cleaned  using  the  ExoSAP-IT®  kit  (Affymetrix 
 
212 #78201), sequenced by the Sanger method (BigDye® Terminator v1.1- Applied Biosystems 
 
213 #4337450) according to  standard procedures and finally purified on EDGE gel filtration 
 
214 cartridges (EdgeBio #42453) prior to injection into an ABI prism 3100 sequencer. 
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215 Results 
 
216 Vascular abnormalities in BN-J rat 
 
217 Retinal vessels were visualized in vivo by fluorescein angiography performed both on 
 
218 wild-type BN-H and pathological BN-J rats at young adult and older age (respectively 8-week 
 
219 and 6-month old). Digital images were taken at early (1-3 min) and later (10 min) time points 
 
220 after fluorescein injection. BN-H rats showed normal vascular aspect and circulatory filling 
 
221 (Figure 1A and B). In 8-week old BN-J rats, at early time points, very subtle capillary 
 
222 dilations could be observed (Figure 1C, inset) that became more visible at later time points as 
 
223 fluorescein leaked from the vascular telangiectasia (Figure 1D, inset).  
 
224  Eyes of older BN-J rats 
 
225 (6 months) presented similar but leaky capillary ectasia (Figure 1E and F, arrowheads of the 
 
226 same color indicate the same spot). Fluorescein angiography performed on younger BN-J rats, 
 
227 at 15 days of life, showed that sparse capillary ectasia was already present at this early age 
 
228 (not shown). 
 
229 On flat-mounted retinas stained with lectin, as compared to BN-H rats (Figure 1G and 
 
230 H), BN-J rats exhibited non-homogenous vascular diameter (Figure 1I, arrows), tortuous 
 
231 capillaries (Figure 1I, arrowheads)  
 
232 and  a  global  deep  capillary  network  disorganization  noted  at 
 
233 different depth (some capillaries are seen underneath) (Figure 1J). Vascular telangiectasia 
 
234 were clearly observed in the inner nuclear layer (INL) deep plexus (inset in Figure 1J, yellow 
 
235 arrow). 
 
236 Images of lectin-labeled flat-mounted retinas were correlated with the corresponding 
 
237 angiographic images showing that telangiectasia and leaky capillaries on angiography (Figure 
 
238 1K) correspond with capillary tortuousness (Figure 1L) and focal capillaries ectasia on flat- 
 
239 mounted retina (Figure 1M, arrowheads of the same color indicate the same spot). Using CD- 
12  
240 31  immunohistochemistry as  endothelial  marker  on  flat-mounted  retinas,  endothelial  cell 
 
241 discontinuity was found to be associated with non-homogenous capillary diameter in BN-J 
 
242 
 
243 
rats, which may partially explain the leakage of fluorescein on angiography (not shown). 
 
244 Morphological retinal lesions in BN-J rat 
 
245 On semi-thin sections of the BN-J retina, at 8 weeks of age, focal disorganization of 
 
246 both the outer nuclear layer (ONL) and INL with loss of the outer segments of photoreceptors 
 
247 (Figure 2B, zones in dark circles) were observed. Intraretinal cysts (asterisks) formed in both 
 
248 the inner (Figure 2C) and the outer retina (Figure 2D). Interestingly, around these focal areas 
 
249 of retinal lamination loss, the gross retina structure appeared preserved, but vascular tortuosity 
 
250 and capillary telangiectasia (white arrows) were noticeable in disorganized (Figure 2D) as 
 
251 well as in normal areas (Figure 2E). Small cysts were also observed surrounding retinal 
 
252 vessels (Figure 2D). At 6 months, BN-J rats presented focal disappearance of the ONL 
 
253 containing photoreceptor cells in numerous areas that were spread across the entire retina (as 
 
254 exampled in Figure 2G). Large intraretinal cysts (Figure 2G and H, asterisk) were specifically 
 
255 observed in BN-J animals, as compared to BN-H rats of the same age (Figure 2F) showing the 
 
256 progression of retinal degeneration. 
 
257 Closer observation showed other abnormalities in the outer retina of 8-week BN-J rats 
 
258 such as focal loss of pigment in retinal pigment epithelial (RPE) cells (Figure 3B, arrow) and 
 
259 pigment migration (Figure 3C, arrows) as compared to BN-H rats (Figure 3A). In the outer 
 
260 retina of 6-month BN-J rats, abnormal neovessels could be observed above RPE (Figure 3E, 
 
261 inset and arrowhead). 
 
262 Transmission  electronic  microscopy  (TEM)  (Figure  3,  lower  panels)  observation 
 
263 confirmed the abrupt transition in between normal and abnormal retinal areas (Figure 3F, 
 
264 circled area). However, even in areas where photoreceptor structure was maintained, focal 
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265 disruption of junction structures (appearing black in TEM) was identified at the OLM  (Figure 
 
266 3F  and  G,  white  arrows  show  loss  of  junctions;  Figure  3G  and  H,  black  arrows  show 
 
267 maintained   junctions).   Swollen   RMG  processes   were   present   between 
 
268 photoreceptor nuclei (Figure 3I, arrowheads), and cysts (Figure 3J, asterisk) appeared as 
 
269 surrounded by membrane-like structure (Figure 3J). 
 
270 To determine at what age retinal abnormalities start, eyes from PN1, PN8 and PN15 
 
271 BN rats were examined. Whilst no difference could be observed in BN-J and BN-H retinas at 
 
272 PN1 and PN8 (Figure 4A, B, D and E), at PN15, sparse zones of irregular and/or without 
 
273 photoreceptor segment elongation were observed in BH-J rat retina (Figure 4F, circled areas), 
 
274 suggesting RMG/photoreceptor interaction abnormalities (Rapaport et al., 2004). Of note, 
 
275 BN-J rats raised in the dark from birth until 3 weeks exhibit similar retinal abnormalities as 
 
276 the  rats  raised  in  normal  light-dark  cycles  (data  not  shown),  suggesting  that  retinal 
 
277 
 
278 
degeneration is not light-dependent. 
 
279 Retinal neuron alterations in BN-J rat 
 
280 As the outer retina of BN-J rat is focally disorganized, we investigated photoreceptors 
 
281 (cones  and  rods),  bipolar  cells  and  their  synapses  using  specific  immunohistochemistry 
 
282 staining. Cone photoreceptors were labeled in adult BN-H and BN-J rats using a cone arrestin 
 
283 antibody staining the entire cone cells including outer segments and synaptic bodies (Figure 
 
284 5A-D). In BN-J rat, their segments and axonal connections were completely absent in some 
 
285 areas of the outer plexiform layer (Figure 5C and D, asterisk). Of note, some cone cells were 
 
286 displaced towards the INL (Figure 5C and D, arrow). Cell count on the entire retinal section 
 
287 showed a reduction of cones in BN-J rats as compared to BN-H (Figure 5E).  Immunostaining 
 
288 of rhodopsin exhibited disappearance of outer segments of rod photoreceptors in the focal 
 
289 disorganized  areas  of  the  BN-J  retina  (Figure  5G,  asterisk),  whilst  the  remaining  outer 
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290 segments (Figure 5G, arrows) appeared shorter than those in the retina of BN-H rat (Figure 
 
291 5F). The rhodopsin positive surface in the BN-J rat was significantly reduced compared to 
 
292 BN-H rat (Figure 5H), suggesting that  rods may be more widely altered than primarily 
 
293 suspected. 
 
294 PKC-α labels the bipolar cells. In BN-H rats, PKC-α expressing cells were located in 
 
295 the INL extending their processes to the innermost part of the inner plexiform layer (Figure 5I 
 
296 and J), while in some areas of the BN-J rat retina, the nuclei of bipolar cell were internally 
 
297 displaced by the nuclei of photoreceptors invading in the INL (Figure 5K and L, circled area). 
 
298 Synaptophysin immune labeling showed focal disruption of synapses in the outer 
 
299 plexiform layer of the BN-J retina (Figure 5O and P), as compared to intact synapses in the 
 
300 
 
301 
BN-H retina (Figure 5M and N). 
 
302 Glial abnormalities in BN-J rat 
 
303 GFAP labels astrocytes and activated RMG cells. GFAP staining in BN-H rats was 
 
304 restricted as expected to RMG end feet and astrocytes (Figure 6A). In BN-J rats, enhanced 
 
305 GFAP fluorescence was observed in Müller end feet, and in activated swollen RMG cells 
 
306 (Figure 6B, filled arrows) extending up to the vascular processes, as demonstrated by the co- 
 
307 labeling of GFAP with CD31 (Figure 6B and upper inset, open arrow). Some cysts appeared 
 
308 surrounded by GFAP labeling (Figure 6B and lower inset, asterisk). On flat-mounted retina of 
 
309 BN-J rat, RMG were highly activated as GFAP staining was spread all along their end feet 
 
310 and processes with hypertrophic apices at the OLM (Figure 6F-H), as compared to BN-H 
 
311 retina (Figure 6C-E). GS is also a Müller cell marker that labels from their end feet to their 
 
312 apical  processes,  as  observed  in  BN-H  rat  (Figure  6I,  6K-M).  In  BN-J  retina,  GS 
 
313 immunoreactivity was decreased in focal areas in between hypertrophic RMG cells (Figure 6J 
 
314 and 6N-P).  GS and CRALBP (another RMG marker) positive RMG cells were significantly 
15  
315 reduced in BN-J rat compared to BN-H rat (Figure 6Q and R). Additional immunostaining 
 
316 experiments using the RMG nuclear marker, p27kip1, confirmed the loss of RMG cells in 
 
317 
 
318 
BN-J rat retina (Figure 7). 
 
319 Early retinal functional abnormalities in BN-J rat 
 
320 To evaluate retinal functional changes in BN-J rats, ERG was performed as early as 3 
 
321 weeks when retinal focal abnormalities were already identified on histology. Overall ERG 
 
322 responses showed a significant reduction in b-wave amplitude and a trend but not significant 
 
323 reduction in the a-wave amplitude, translating the post-receptoral disturbance of the visual 
 
324 
 
325 
signal particularly at the bipolar and RMG cells (Figure 8A and B). Scotopic ERGs showed 
significant reduced a and b wave amplitudes even at low intensities (0.1 cd.s.m-2) (Figure 8C 
326 and  D),  while  no  significant  difference  was  observed  in  photopic  ERGs  (not  shown), 
 
327 suggesting that rod function is affected earlier than cone function, a finding also observed in 
 
328 
 
329 
MacTel 2 patients (Schmitz-Valckenberg et al., 2008). 
 
330 Genetic analyses 
 
331 In humans, mutations in the crb1 gene usually causes recessively inherited retinitis 
 
332 pigmentosa with preserved para-arteriolar RPE and Leber congenital amaurosis (congenital 
 
333 retinal  blindness)  (den  Hollander  et  al.,  2004),  but  less  frequently  it  causes  retinitis 
 
334 pigmentosa  with  retinal  cysts  and  peripheral  (non-macular)  telangiectasia,  potentially 
 
335 associated at late stages with vascular coats-like telangiectasia (den Hollander et al., 2004; 
 
336 Henderson et al.). We therefore screened for mutations in the entire coding region of crb1 in 
 
337 BN-H and BN-J rats. In these latter animals, we identified a homozygous insertion-deletion 
 
338 (indel) in exon 6. This small DNA rearrangement (c.1685_1698delinsCAAGATGG; reference: 
 
339 NM_001107182.1) involved the ablation of 14 nucleotides of the wild-type rat DNA sequence 
16  
340 and the insertion of 8 new ones, while preserving at the same time the canonical open reading 
 
341 of the gene (Figure 9). At the protein level, this change would translate into the replacement 
 
342 of amino acid residues 562 to 566 (NTSDG) with 3 new ones: TRW. Residues 562 to 566 of 
 
343 CRB1 are identical in human and rat and are well conserved across vertebrates (the last three 
 
344 of which, SDG, being invariant from man to zebrafish, not shown) indicating that this portion 
 
345 of the protein may be rather important for its function. Finally, as expected, we did not detect 
 
346 any DNA variation within the crb1 coding sequence in BN-H animals or in the karyotype of 
 
347 BN-J rats. 
 
348 To ascertain whether this change in crb1 represented a true mutation responsible for 
 
349 the retinal phenotype of BN-J rats, we analyzed the co-segregation of the indel with the 
 
350 aberrant retinal phenotype, over an extended set of animals that were the offspring of targeted 
 
351 mating. Crosses of pure parental strains (BN-H x BN-J) resulted in an F1 composed of 18 
 
352 phenotypically normal rats, as ascertained by retinal histology, which were verified to be 
 
353 heterozygous for the BN-J indel. Four F1 couples were then cross-bred, to produce an F2 
 
354 composed of a total of 30 pups, which as adults were all phenotyped and genotyped by 
 
355 investigators who were reciprocally masked. Out of these 30 animals, 24 had normal retinas, 
 
356 while  6  presented  with  defects  that  were  indistinguishable  from  those  displayed  by the 
 
357 parental  BN-J  strain. Genotyping showed that  all specimens with abnormal retinas were 
 
358 homozygotes for the BN-J indel, whereas those with normal retinal morphology were either 
 
359 wild-type or heterozygotes (5 and 19 animals, respectively). Taken together, these results 
 
360 
 
361 
indicate that the crb1 indels detected in BN-J rats acts as a recessive allele to determine the 
observed retinal phenotype in homozygous animals, with an associated P-value < 2.5 x 10-7 
362 
 
363 
 
364 
(likelihood  of  phenotypes  and  genotypes  co-occurring  by  chance,  i.e.  the  retinal  BN-J 
phenotype not being associated with the detected indel mutation= 0.256 x 0.7524). 
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365 Mislocalization of CRB1 protein in BN-J rat 
 
366 We further studied CRB1 expression by immunofluorescence in adult BN-J and BN-H 
 
367 rats. In BN-H rat retina, CRB1 was observed particularly in the apical region above the OLM 
 
368 labeled by GS (Figure 10A-C, left inset and arrows). CRB1 was co-localized with GS in the 
 
369 microvilli of RMG cells (Figure 10C, arrowheads in the right inset). CRB1 was also diffusely 
 
370 distributed in the inner segments of photoreceptors (Figure 10A and D). Double staining of 
 
371 CRB1 and PNA showed co-localization in the inner segments of cone cells (Figure 10F, 
 
372 arrowheads in the inset). In BN-J rat retina, CRB1 was still expressed in photoreceptor inner 
 
373 segments (Figure 10G and J-L, inset), but its localization in the sub-apical region was missing 
 
374 and CRB1 did not co-localized with GS (Figure 10G-I, inset). The CRB1 phenotype of BN-J 
 
375 rats is therefore more pronounced in RMG cells and results in a mislocalization of the protein 
 
376 
 
377 
in the RMG/photoreceptor cell junction. 
 
378 Transcriptome analysis and deregulated signaling pathways in BN-J retinal Müller glial 
 
379 cells 
 
380 To identify the molecular mechanisms linking CRB-1 to the BN-J retinal phenotype, 
 
381 we analyzed the differential transcriptome of primary RMG cells extracted at PN 17, a time 
 
382 when RMG cells have acquired polarization and differentiation markers (Wurm et al., 2006), 
 
383 from BN-J, BN-H and control wild-type Lewis rats. The results showed respectively 11808, 
 
384 11358 and 11873 expressed genes (FPKM values >=2).  Differential expression analyses were 
 
385 performed between the three strains. A total of 6021 differentially expressed genes resulted 
 
386 from JL comparison (between BN-J and Lewis RMGs), 4517 differentially expressed genes 
 
387 from JH comparison (between BN-J and BN-H RMGs), and 3253 differentially expressed 
 
388 genes from HL comparison (between BN-H and Lewis RMGs) (Figure 11). The data showed 
 
389 an expression profile in BN-J RMG that is further away from the ones of BN-H or Lewis 
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390 RMG than between these two last strains together. The common differentially expressed 
 
391 genes between both JL and JH are of importance as they may contain the ‘BN-J specific set of 
 
392 genes’  whose  mis-regulation  plays  a  predominant  role  in  the  early  development  of  the 
 
393 pathological process (observed in the BN-J strain). The corresponding intersection contains a 
 
394 total  of  3336  genes  (corresponding  to  respectively  73%  and  53%  of  the  JH  and  JL 
 
395 differentially expressed genes). As expected, BN-J and BN-H are closer together than each of 
 
396 them separately with the Lewis strain. Moreover, the majority (73%) of the JH differentially 
 
397 expressed genes are also differentially expressed between the pathological BN-J and a further 
 
398 distant wild-type strain, such as the Lewis strain. The BN-J specific set of genes represent 
 
399 candidate genes potentially involved in the pathological development of BN-J rats. Of note, 
 
400 the results showed a significant reduction in crb1 expression in RMG cells (crb1 gene name 
 
401 referred as D3ZZL8_RAT) from BN-J and BN-H as compared to the Lewis control (log2FC 
 
402 JL=-3.76; log2FC HL=-3,05) and a reduction in BN-J as compared to BN-H (log2FC JH=- 
 
403 0.72) . 
 
404 In order to decipher the essential functions of the RMG cells at this early stage, we 
 
405 performed a pathway enrichment analysis on the three studied strains (Table 1). With the aim 
 
406 of distinguishing between the potentially pathological pathways and the strain-related ones, 
 
407 we conducted further pathway enrichment analyses on the JL, JH and HL sets of genes (Table 
 
408 2). In agreement with the previous results on gene-based distances between strains (number of 
 
409 mis-regulated  genes  for  log2FC  JL>log2FC  JH>log2FC  HL>0.6  or  log2FC  JL<log2FC 
 
410 JH<log2FC HL<0.6), we found 48, 28 and 10 enriched signaling pathways in JL, JH and HL 
 
411 respectively. After enriched pathways have been grouped by similar functions, we focused on 
 
412 the pathways that were enriched in both JL and JH sets of genes (i.e. the ‘BN-J specific set of 
 
413 genes’).  Among  those  pathways,  TGF  Beta  Signaling,  Matrix  Metalloproteinases,  Kit 
 
414 Receptor Signaling, Type II interferon Signaling, MAPK Cascade, Growth factor Signaling 
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415 Pathways,  Inflammatory  Pathways,  G  Protein  Signaling  Pathways,  Regulation  of  Actin 
 
416 Cytoskeleton, Cardiovascular Signaling, Calcium regulation in the cardiac cell and EGFR1 
 
417 Signaling Pathway were found. 
418 In addition, we have compared our rat data to previously described classical Müller 
 
419 glial markers and Müller glial markers derived from the mouse transcriptome study of Roesch 
 
420 K (Roesch et al., 2008), and found that 64.7% (11 out of 17) of those Müller glia markers are 
 
421 down-regulated in BN-J as compared to BN-H or Lewis rat, supporting the fact that the 
 
422 number of mature Müller glia is reduced in BN-J retina. The down-regulated markers are 
 
423 Aqp4,  Clu,  Kir4.1/Kcnj10,  S100a16,  CRALBP-1/Rlbp1,  GS/Glul,  Dkk3,  Chx-10/Vsx2, 
 
424 
 
425 
Spbc25/Spc25, GPR37, and Car2. 
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434 Discussion 
 
435 This report describes a recessively inherited retinal phenotype of a rat strain carrying 
 
436 abnormalities as observed in the human MacTel 2 disease: focal loss of retinal lamination, 
 
437 OLM disruptions, retinal cysts, RMG, photoreceptor and RPE alterations associated with 
 
438 retinal telangiectasia and late stage intraretinal neovascularization. It was found that this 
 
439 phenotype is caused by a new mutation in exon 6 of rat crb1. This model was then used to 
 
440 decipher the molecular pathways deregulated in RMG cells, and thus provided a full spectrum 
 
441 of targets to study the pathogenesis of MacTel 2 and of other retinal diseases associated with 
 
442 telangiectasia. 
 
443 A specific focus directed towards RMG cells in the histology of a MacTel 2 patient 
 
444 retina showed prominent loss of RMG cell markers in the central retina and RMG metabolic 
 
445 disorders (Powner et al., 2010). The link between RMG cell depletion and retinal vessel 
 
446 telangiectasia  was  further  highlighted  by  the  group  of  Mark  Gillies,  who  generated  a 
 
447 transgenic  mouse  model  with  conditional  RMG  cell  ablation  by using  a  portion  of  the 
 
448 regulatory region of the retinaldehyde binding protein 1 gene. The selective killing of RMG 
 
449 cells  in  adult  mice  led  to  photoreceptor  apoptosis,  vascular  telangiectasia,  blood–retinal 
 
450 barrier breakdown and to late intraretinal neovascularization (Shen et al., 2012). Interestingly, 
 
451 the retinal pathology of this animal model is very similar to the one displayed by the BN-J rat 
 
452 reported  here,  for  which  retinal  abnormalities  development  coincides  with  RMG  cell 
 
453 maturation in rats (Wurm et al., 2006). 
 
454 In this context, the differential transcriptomic analysis of mature RMG cells from BN- 
 
455 J rats and two control strains (BN-H and Lewis) was performed. A restricted list of pathways 
 
456 was identified, most of which were found also in the whole retina transcriptomic analysis of 
 
457 the  transgenic  conditional  mice  model  described  above  (Chung  et  al.,  2013).  These 
 
458 similarities support the hypothesis that early Müller glia dysregulation could induce the retinal 
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459 vascular pathology observed in the BN-J rat, although it is still unclear whether a focal loss of 
 
460 RMG  cells  is  required  or  whether  prior  RMG  dysfunction  alone  could  induce  retinal 
 
461 alterations observed in MacTel 2. 
 
462 RMG cell processes surround retinal capillaries and the basement membrane of the 
 
463 perivascular Müller cells merge with the self-propagating vessels wall, demonstrating the very 
 
464 close interaction of RMG cells with the retinal vasculature. On the other hand, RMG cells 
 
465 communicate with photoreceptor cells through adherens junctions and serve as sensors for 
 
466 any environmental changes. In the healthy retina, RMG cells contribute to control retinal 
 
467 angiogenesis through the production of the anti-angiogenic PAI-1 factor (Abukawa et al., 
 
468 2009) and meteorin, which interestingly also controls GFAP expression (Lee et al., 2010). 
 
469 Indirect  evidence  originating  from  in  vitro  studies  suggest  that  RMG  cells  could  also 
 
470 participate in the blood retinal barrier through TGF-beta and MMP9 expression (Behzadian et 
 
471 al., 2001), a pathway and a factor respectively, that were identified in the transcriptomic 
 
472 differential analysis of BN-J rat. RMG cells are therefore now viewed as a component of the 
 
473 neurovascular unit of the retina (Reichenbach and Bringmann, 2013). 
 
474 The genetic analysis of BN-J rat showed that the retinal phenotype is transmitted as a 
 
475 Mendelian recessive trait, apparently in contrast with current knowledge on inheritance of 
 
476 human macular telangiectasia (Parmalee et al., 2012). The disease allele is an indel mutation 
 
477 in exon-6 of the crb1 gene, a DNA change that has not been described previously in other 
 
478 crb1-related retinal degenerations in humans or in animal models. The recessive inheritance 
 
479 of the rat phenotype seems to suggest that the indel leads to some crb1 loss of function, 
 
480 completely  tolerated  in  heterozygotes.  However,  it  is  still  unclear  whether  the  mutation 
 
481 completely abrogates protein functionality or represents a hypomorphic allele that still allows 
 
482 some  residual  activity.  The  preservation  of  crb1  canonical  reading  frame,  despite  five 
 
483 seemingly important amino acids being replaced, is compatible with this latter hypothesis and 
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484 may support the notion that the rat phenotype similar to the human MacTel 2 phenotype could 
 
485 be considered as a milder manifestation of more severe crb1-linked retinal degenerations. 
 
486 Despite RNA sequencing showing a significant reduction in crb1 (ENSRNOG00000010903) 
 
487 expression in RMG cells from BN-J and BN-H as compared to the Lewis control a reduction 
 
488 in BN-J as compared to BN-H, the variant CRB1 protein remains present in the retina of BN-J 
 
489 rats. But CRB1 protein is mislocalized and loses its concentration in the sub-apical regions 
 
490 above the adherens junctions between RMG and photoreceptors of BN-J retina. Amongst 
 
491 proteins involved in the correct localization of CRB, the small GTPase Cdc42 that belongs to 
 
492 the  Ras  superfamily  is  of  particular  interest  since  it  play  a  major  and  unique  role  in 
 
493 epithelium permeability (Citalan-Madrid et al., 2013) and retina-specific Cdc42-knockdown 
 
494 mice showed not only retinal degeneration but also important vascular abnormalities (Heynen 
 
495 et al., 2013). 
 
496 In contrast to phenotypes resulting from other crb1 mutations, the BN-J rat presents 
 
497 early retinal vascular leaky telangiectasia and late intraretinal neovascularization and this 
 
498 degeneration  is  not  light-dependent.  These  differences  can  result  from  different  type  of 
 
499 mutations,   or   from   different   genetic   set-up   displayed   by   different   animal   species. 
 
500 Interestingly, using exome sequencing analysis, crb1 defect recently was associated with an 
 
501 unusual  form  of  macular  dystrophy,  suggesting  that  some  CRB1  dysfunction  could  be 
 
502 specifically expressed in the macula (Tsang et al., 2014). 
 
503 CRB proteins interact with β-catenin, N-cadherin and with the PAR3/PAR6/atypical 
 
504 PKC pathway and with PALS-1/MPP3/MPP5 that belongs to the MAGUK proteins (Alves et 
 
505 al., 2014). Complex interactions maintain this molecular scaffold and alterations of different 
 
506 partners   may   induce   variable   retinal   phenotypes.   For   example,   progressive   retinal 
 
507 degeneration  and  vascular  abnormalities  have  been  recently  described  in  a  conditional 
 
508 knockout mouse for MPP3, that is normally localized in apices of RMG and regulates the 
23  
509 levels  of  PALS1  (Dudok  et  al.,  2013).  This  suggests  that  mutations  in  genes  encoding 
 
510 different  proteins  interacting  with  CRB  could  induce  retinal  degeneration  and  vascular 
 
511 phenotypes.  Interestingly, retinal vessel development was recently shown to be dynamically 
 
512 regulated by VEGF receptor endocytosis and the activity of cell polarity proteins, particularly 
 
513 PAR3/atypical PKC (Nakayama et al., 2013). In addition, we recently found that the activity 
 
514 of atypical PKC zeta in the retina is deregulated early by hyperglycemia and contributes to 
 
515 OLM disruptions (Omri et al., 2013), which could be a link between increased susceptibility 
 
516 to MacTel 2 in diabetic patients (Clemons et al., 2013).  So far, attempts to find the gene(s) 
 
517 responsible for MacTel 2 by candidate-gene screening have been unsuccessful (Parmalee et 
 
518 al., 2010). Whether CRB1 and/or other proteins, associated with adherens junctions between 
 
519 cone photoreceptors and RMG cells in the macula, are associated with MacTel 2 phenotype in 
 
520 humans should be evaluated. 
 
521 The exact mechanisms linking CRB1 mislocalization to the BN-J retina phenotype are 
 
522 yet to be determined. To identify potential pathways, we studied the molecular imbalances of 
 
523 primary BN-J developing RMG cells mutated for crb1 using transcriptome analysis. Pathways 
 
524 such as TGF Beta Signaling, Matrix Metalloproteinases, Kit Receptor Signaling, Type II 
 
525 interferon  Signaling,  MAPK  Cascade,  Growth  factor  Signaling  Pathways,  Inflammatory 
 
526 Pathways, G Protein Signaling Pathways, Regulation of Actin Cytoskeleton, Cardiovascular 
 
527 Signaling, and EGFR1 Signaling Pathway were found to be deregulated in the rat model. 
 
528 Among these, known cellular process and pathways associated with MacTel 2 disease were 
 
529 found,  such  as  (Cardio)Vasculogenesis,  Apoptosis,  or  Oxidative  stress.  Additionally, 
 
530 ‘Regulation of Actin Cytoskeleton’ and ‘Calcium Regulation in the Cardiac Cell’ contained 
 
531 genes associated with adherens junctions, where CRB1 appears to be mislocalized in BN-J rat. 
 
532 Focal adhesion and Integrin-mediated Cell Adhesion pathways, regulating the blood-retinal 
 
533 barrier,  were  also  found  to  be  affected  in  BN-J  rats.  TGF  Beta  Signaling  and  Matrix 
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534 Metalloproteinases were strongly dysregulated. Of note, a direct correlation of TGF beta 
 
535 effects on MMP9 as a potential cause of the blood-retinal barrier breakdown was already 
 
536 hypothesized (Behzadian et al., 2001). Small G proteins (such as RAP1 that was identified in 
 
537 the transcriptomic differential analysis of BN-J rat) have also been reported to play a critical 
 
538 role in the stabilization of endothelial junctions (Wilson and Ye, 2014). Several studies have 
 
539 also established the role of growth factors (in particular VEGF) and inflammation in the 
 
540 pathophysiology of the MacTel 2 disease. Moreover, different clinical trials with anti-VEGF 
 
541 compounds (Kovach and Rosenfeld, 2009; Charbel Issa et al., 2011; Narayanan et al., 2012) 
 
542 and a retrospective interventional case description on the positive effect of topical anti- 
 
543 inflammatory agents on a phakic cystoid macular edema secondary to idiopathic macular 
 
544 telangiectasia have been reported (Dunn et al., 2013). 
 
545 In conclusion, we have identified and characterized spontaneous retinal abnormalities 
 
546 in a strain of BN rats that are very close to other models of MacTel 2 created by depletion of 
 
547 RMG cells and strongly reminiscent of the human phenotype. We have identified the genetic 
 
548 mutation  responsible  for  this  phenotype  in  the  rat  crb1  gene,  and  have  studied  the 
 
549 transcriptome of RMG cells from these animals, highlighting the involvement of numerous 
 
550 cellular pathways and potential regulatory targets.  This rat model could be used to evaluate 
 
551 
 
552 
potential new therapeutic options for retinal telangiectasia. 
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701 Legends to figures 
 
702 
 
Figure 1. Vascular abnormalities in BN-J rats. 
 
703 In vivo fluorescein angiography of retinal vessels of BN-H and BN-J rats (A-F). 
 
704 Normal retinal vessels of BN-H rat at early (1-3 min, A) and late phase (10 min, B) of the 
 
705 angiographic sequence. 
 
706 8 week-old BN-J rat exhibits subtle capillary dilation hardly detected in the early phase (1-3 
 
707 min) of angiography (C, arrowhead in the inset), that becomes more visible with leakage at 
 
708 later time point of 10 min (D and inset).  At 6 months of age, similar but leakier capillary 
ectasia 
 
711 are observed (E and F, arrowheads, the same color indicates the same spot). Hyperfluorent 
 
712 leaking dots are observed at 1-3 min, and their size increases at 10 min. 
 
713 Bar: 200 µm. 
 
714 Confocal imaging of lectin-stained retinal vessels on flat-mounted retinas from BN-H and 
 
715 BN-J rats (G-J, L and M). 
 
716 Normal retinal vascular network (green) at the nerve fiber layer (NFL)
 
717 and in the deep plexus at the inner nuclear layer (INL) from BN-H rat (G and H). 
 
718 In  BN-J  rat  retina,  irregular  vascular  diameter  (white  arrows)  and  increased  tortuosity 
 
719 (arrowhead) are observed at the NFL level (I).  
32  
 720  In the INL, disorganized capillary plexus is 
 
721 observed (J), together with multiple capillary telangiectasia (inset, yellow arrow).
 
723 Images of a lectin-labeled flat-mounted retina of BN-J rat 
 
724 are linked to their corresponding angiographic pattern (K). Higher magnifications of the 
 
725 lectin-labeled  vessels  show  that  leaky  telangiectasia  (in   K)  correspond  to  capillary 
33  
726 tortuousness (L) and focal capillary ectasia (M). Arrowheads of the same color indicate the 
 
727 same spot. 
 
728 
 
729 
Bar: G-J, 20 µm; K, 200 µm; L and M, 50 µm. 
 
 
730 Figure 2. Retinal morphology of BN-H and BN-J at 8 weeks and 6 months. 
 
731 As compared to the normally developed retina of BN-H rat at 8 weeks (A), the retina of BN-J 
 
732 rat shows focal disorganization of the outer retinal layers (B, dark circles) where segments are 
 
733 not formed and nuclei of photoreceptors dive towards the retinal pigment epithelium (RPE). 
 
734 In areas where segments are present, swollen retinal Müller glial cells can be observed (B, 
 
735 black arrow). Cysts (asterisks) can be found in both the inner (C) and the outer (D) retina. 
 
736 Telangiectasia are also identified on histological sections (D and E, white arrow). 
 
737 At 6 months, BN-H rat retina is unchanged (F), whilst the retina of BN-J rat shows variable 
 
738 degree of degeneration. Photoreceptors have totally disappeared in some areas (G) and cysts 
 
739 are more abundant with irregular shapes (G and H, asterisks). 
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740 GCL, ganglion cell layer; IPL, inner plexiform layer; INL; inner nuclear layer; OPL, outer 
 
741 plexiform layer; ONL; outer nuclear layer; IS/OS; inner and outer segments of photoreceptors. 
 
742 
 
743 
Bar: 20µm. 
 
 
744 Figure 3. Outer retinal alterations in BN-J rats. 
 
745 A-E: histological sections of the outer retina; F-J: transmission electronic microscopy (TEM) 
 
746 images. 
 
747 Contrasting with the heavy pigments located in the apical side of retinal pigment epithelium 
 
748 (RPE) in BN-H retina (A), melanosomes are poorly formed in BN-J rat at 8 weeks even in 
 
749 areas  where  the  segments  have  formed  (B,  black  arrow)  and  pigments  migrate  in  the 
 
750 photoreceptor segment layer (C, black arrows). At 6 months, the outer retina of BN-H rat does 
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751 not change (D), while abnormal vessels are observed between RPE cells and the degenerated 
 
752 retina of BN-J rat (E, inset and black arrowhead), potentially   corresponding   to 
 
753 neovascularization. 
 
754 TEM analysis allows detection of more subtle changes in BN-J retina such as focal decrease 
 
755 in  junction  structures  (F  and  G,  white  arrows)  at  the  outer  limiting  membrane  (OLM), 
 
756 alternating with normal OLM structures (G and H, black arrows).  Abrupt disorganization of 
 
757 retinal layers is observed (F, dark circle). Swollen retinal Müller glial cells (I, in between the 
 
758 white arrowheads) are identified in the outer nuclear layer (ONL) and cysts (F and J, asterisks) 
 
759 are surrounded by a membrane-like structure, suggesting intracellular swollen. 
 
760 IS, inner segments of photoreceptors; OS, outer segments of photoreceptors. 
 
761 
 
762 
Bar: A-E, 20 µm; F, 25 µm; G, I and J, 10 µm; H, 2 µm. 
 
 
763 Figure 4. Post natal retinal development morphology of BN-H and BN-J rats. 
 
764 From post natal day 1 (PN1), to post natal day 8 (PN8), the neuronal layers are segmented 
 
765 into inner neuroblastic (INbL) and outer neuroblastic layers (ONbL) both in BN-H (A and B) 
 
766 and BN-J (D and E). However, from PN8 to post natal day 15 (PN15), whilst inner and outer 
 
767 segments (IS and OS) elongate normally in the BN-H retina (C), focal areas without segment 
 
768 elongation and persistent neuroblastic nuclei (circled areas) are observed in BN-J retina (F). 
 
36  
769 Dilated capillaries can be observed in the inner nuclear layer (INL) of BN-J retina (F, arrow). 
 
770 
 
771 
GCL, ganglion cell layer; ONL, outer nuclear layer. Bar: 20 µm. 
 
 
772 Figure 5. Immunohistochemistry of retinal neurons of BN-J rats. 
 
773 Different neuronal types are immunostained with specific markers in the BN-H retina: 
 
774 Cone arrestin stains the entire cone photoreceptors including outer segments and synaptic 
 
775 bodies (A), rhodopsin stains the outer segments (OS) of rod photoreceptors (F), Protein 
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776 Kinase  C-alpha  (PKC-α)  labels  the  bipolar  cells  (I)  and  synaptophysin  labels  synaptic 
 
777 connections between retinal neurons (M). B, F, J and N are merged images with DAPI (Blue). 
 
778 In the BN-J retina, cone segments are shorter or even absent (C, arrowhead) and cones are 
 
779 missing in cystic formations (C, asterisk) and nuclei of some cones without segments are 
 
780 displaced (C, arrow). Cell count shows significant reduction of cone cells in BN-J rats (E). 
 
781 Rod are absent in disorganized area (G, asterisk) and their segments are shorter in other 
 
782 regions (G, arrows) suggesting segment elongation disruption. Quantification of rhodopsin 
 
783 positive surface shows significant decrease in rod outer segment areas in BN-J rats (H). In 
 
784 disorganized areas, nuclei of bipolar cell are internally displaced (K, circle) and neuronal 
 
785 synapses are disrupted in the outer plexiform layer (OPL, O, arrows). D, G, L and P are 
 
786 merged images with DAPI. 
 
787 GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; ONL, outer 
 
788 nuclear layer. 
 
789 Bar: A-D, F, G and M-P, 50µm; I-L, 20µm. 
 
790 
 
791 
E and H: n=5 rats per strain; **, P < 0.01. 
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Figure 6. Retinal Müller glial morphologic alterations in sectioned and flat-mounted 
 
793 BN-J retinas. 
 
794 Glial  fibrillary  acidic  protein  (GFAP)  stains  retinal  Müller  glial  (RMG)  end  feet  and 
 
795 astrocytes on  BN-H retinal  cross  section  (A).  On flat-mounted retina,  GFAP  staining is 
 
796 surrounding vessels (labeled with lectin) in the nerve fiber layer (NFL, C-D) and in RMG 
 
797 apices in the outer limiting membrane (OLM, E). In BN-J retina, activated RMG cells extend 
 
798 up to the sub-retinal space in disorganized areas (B, filled arrows). Activated RMG cells 
 
799 surround vessels in the inner nuclear layer (INL, B, upper inset, open arrow) and form the 
 
800 border of cysts (B, lower inset, asterisk). 
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801 On flat-mounted BN-J retina, GFAP is enhanced in the RMG end feet in the NFL (F and G), 
 
802 and extends up to OLM where swollen apices (H, filled arrows) and disorganization of RMG 
 
803 are observed (H). 
 
804 In BN-H retina, glutamine synthetase (GS) stains the RMG from their end feet to processes 
 
805 around the vessels (labeled with lectin) and to their apices (retinal section I and flat-mounted 
 
806 retina K-M). In BN-J retina, GS immunoreactivity is enhanced in hypertrophic RMG and 
 
807 reduced in the surrounding areas, as observed in both retinal section (J, in between the 
 
808 arrowheads) and flat-mounted retina (N-P, asterisks), suggesting focal loss of RMG cells. 
 
809 GS positive and also cellular retinaldehyde-binding protein (CRALBP, another RMG marker) 
 
810 positive RMG cells are significantly decreased in BN-J rat retinas (Q and R). 
 
811 GCL, ganglion cell layer; IPL, inner plexiform layer; ONL, outer nuclear layer. 
 
812 Bar: A-B and I-J, 50 µm; C-D, F-G, K-L and N-O, 100 µm, E, H, M and P, 50 µm. 
 
813 
 
814 
Q and R: n=5 rats per strain; **, P < 0.01. 
 
 
 
815 Figure 7. Loss of Müller glial cells in BN-J rat retinas. 
 
816 Retinal Müller glial cells (RMG) were immunostained with p27kip1, a RMG nuclear marker. 
 
40  
817 P27kip1 positive nuclei in the inner nuclear layer (INL) are reduced in the BN-J rat retina (C) 
 
818 compared to BN-H rat retina (A). B and D are merged images with DAPI. Bar: 50 µm. 
 
819 Cell count of p27kip1 positive RMG shows significant decrease in BN-J rat retinas. n=7 rats 
 
820 
 
821 
for BN-H and 6 rats for BN-J; **, P < 0.01. 
 
 
 
822 Figure 8. Early retinal function alterations in BN-J rats. 
 
823 Electroretinogram (ERG) was performed on 3-week BN-H and BN-J rats. While global ERG 
 
824 responses show a trend but not significant reduction in a-wave amplitude (A), the b-wave 
 
825 amplitude is significantly decreased (B), suggesting post-receptoral disturbance of the visual 
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826 
 
827 
signal in the inner retina. Scotopic ERG shows a significant reduction in a- (C) and b-wave 
amplitudes (D) from 0.1 to 3 cd.s/m2 suggesting intense rod visual pathway dysfunction. 
828 
 
 
829 
n=5 rats for BN-H and 4 for BN-J. *, P < 0.05. 
 
 
 
830 Figure 9. Electropherograms of part of crb1 exon 6 in BN-H and BN-J rats. 
 
831 
 
832 
The insertion-deletion in the BN-J sequence is indicated by solid black lines. WT: wild-type. 
 
 
833 
Figure 10. CRB1 immuno-localization in BN-H and BN-J retinas. 
 
834 In BN-H retina, CRB1 localizes in the sub-apical region above the level of outer limiting 
 
835 membrane (OLM) labeled with glutamine synthetase (GS, A-C, open arrows in the left inset). 
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 836 Higher magnification shows co-localization of CRB1 with GS in the microvilli of retinal 
 
837 Müller glial cells (arrowheads in the right inset). CRB1 stains also the inner segments (IS) of 
 
838 photoreceptors  (A  and  D).  Double  staining  with  peanut  agglutinin  (PNA,  E)  shows  co- 
 
839 localization of CRB1 with cone IS (F, arrowheads in the inset). 
 
840 In BN-J retina, CRB1 loses its localization in the sub-apical region (G-I, inset), OLM is even 
 
841 disrupted in disorganized areas (H, filled arrow). In organized areas, CRB1 remains in the 
 
842 photoreceptor IS (J). Double staining with PNA (K) shows co-localization with cone IS (L, 
 
843 arrowhead in the inset). 
 
844 
 
845 
ONL, outer nuclear layer. Bar: 20 µm. 
 
 
846 Figure 11. Crossing of the differential expression analyses of BN-J, BN-H and Lewis 
 
847 PN17 primary retinal Müller glial cells. 
 
848 Venn diagram showing the number of over-expressed (in green) and under-expressed genes 
 
849 
 
850 
(in red) that are shared and unique for each comparison
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Table 1. Signaling pathways enrichment in primary retinal Müller glial cells from 851 
Brown Norway from Janvier, Harlan and from Lewis rat strains. 852 
 Enriched in adj. Pval 
Pathways BNJ BNH Lewis BNJ BNH Lewis 
D-GLOCUSE-INS1-RXRA     4,0E-02 5,5E-02 6,5E-02 
Pentose Phosphate Pathway    5,0E-02 5,8E-02 6,3E-02 
Type II interferon signaling (IFNG)    9,3E-03 6,1E-02 1,4E-01 
Urea cycle and metabolism of amino groups     1,5E-02 2,0E-02 7,2E-02 
ATM    4,7E-05 4,9E-04 1,0E-04 
Adipogenesis    1,8E-03 6,8E-06 2,9E-06 
Alpha6-Beta4 Integrin Signaling Pathway    2,5E-03 1,0E-02 3,2E-03 
Androgen Receptor Signaling Pathway    8,0E-16 6,6E-16 2,5E-14 
Apoptosis    2,7E-09 1,0E-08 5,8E-09 
Apoptosis Modulation by HSP70    4,8E-04 4,3E-03 6,6E-05 
B Cell Receptor Signaling Pathway    1,3E-19 2,9E-19 1,5E-17 
Beta Oxidation Meta Pathway    4,1E-03 6,2E-03 6,8E-04 
CDKN1A-EGF-CREB    1,0E-08 2,7E-09 7,8E-09 
Calcium Regulation in the Cardiac Cell    1,6E-02 1,8E-03 7,5E-05 
Cardiovascular Signaling    6,7E-03 3,4E-03 1,4E-03 
Cell cycle    3,8E-14 1,5E-14 6,6E-13 
Cholesterol Biosynthesis    9,6E-04 1,3E-03 1,5E-03 
Cholesterol metabolism    9,3E-05 1,6E-04 1,1E-03 
Cytoplasmic Ribosomal Proteins    1,7E-26 2,6E-25 2,3E-24 
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DNA Replication    2,6E-07 2,1E-09 8,3E-08 
Delta-Notch Signaling Pathway    1,0E-09 1,4E-11 2,0E-09 
Diurnally regulated genes with circadian orthologs    8,1E-07 2,0E-06 5,2E-07 
EBV LMP1 signaling    4,5E-03 1,3E-03 1,7E-03 
EGFR1 Signaling Pathway    1,3E-20 3,7E-20 6,4E-20 
EPO Receptor Signaling    1,4E-02 5,7E-03 2,4E-02 
Electron Transport Chain    2,6E-25 3,3E-24 1,3E-24 
Endochondral Ossification    8,8E-03 1,3E-03 2,0E-03 
ErbB signaling pathway    9,8E-03 2,6E-03 9,7E-03 
Eukaryotic Transcription Initiation    6,9E-10 1,7E-09 3,1E-09 
FAS pathway and Stress induction of HSP regulation    1,4E-08 3,9E-07 6,7E-07 
Fatty Acid Beta Oxidation    2,1E-03 3,3E-03 3,3E-04 
Fatty Acid Beta Oxidation 1    2,3E-02 3,2E-02 4,3E-03 
Fatty Acid Beta Oxidation 3    2,0E-02 2,4E-02 2,7E-02 
G Protein Signaling Pathways    9,4E-06 1,8E-08 4,7E-08 
G1 to S cell cycle control    5,7E-08 4,7E-09 6,8E-08 
G13 Signaling Pathway    2,2E-03 2,8E-04 8,5E-05 
Glycogen Metabolism    2,0E-03 7,0E-04 9,5E-04 
Glycolysis and Gluconeogenesis    1,7E-02 1,1E-02 1,5E-02 
Heme Biosynthesis    2,3E-02 2,8E-02 3,1E-02 
Homologous recombination    1,0E-02 1,3E-02 1,6E-02 
IL-1 Signaling Pathway    1,2E-03 1,6E-03 1,1E-02 
IL-2 Signaling Pathway    4,9E-09 2,9E-09 4,2E-08 
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IL-3 Signaling Pathway    2,3E-13 2,4E-14 1,1E-13 
IL-4 Signaling Pathway    8,6E-11 2,6E-10 7,0E-10 
IL-5 Signaling Pathway    2,4E-10 8,2E-11 2,1E-09 
IL-6 Signaling Pathway    1,9E-15 1,2E-16 4,9E-16 
IL-7 Signaling Pathway    4,1E-08 9,5E-08 1,9E-07 
IL-9 Signaling Pathway    3,9E-04 5,9E-04 7,6E-04 
Id Signaling Pathway    2,6E-04 1,5E-04 6,5E-05 
Insulin Signaling    1,2E-15 6,0E-16 4,9E-19 
Integrin-mediated cell adhesion    3,2E-06 3,4E-06 6,8E-07 
Keap1-Nrf2    3,4E-02 4,3E-02 1,0E-02 
Kit Receptor Signaling Pathway    3,6E-08 1,9E-08 2,3E-07 
MAPK Cascade    2,1E-04 5,3E-05 4,2E-07 
MAPK signaling pathway    9,2E-16 2,2E-15 3,3E-15 
Mitochondrial Gene Expression    3,1E-03 4,4E-03 5,5E-03 
Mitochondrial LC-Fatty Acid Beta-Oxidation    1,9E-03 2,6E-03 3,2E-03 
Myometrial Relaxation and Contraction Pathways    1,2E-07 3,3E-08 2,0E-09 
NR3C1-PKL1    4,2E-06 9,9E-06 1,7E-05 
Non-homologous end joining    3,6E-02 4,3E-02 4,7E-02 
Notch Signaling Pathway    1,4E-03 2,3E-04 3,4E-03 
Nucleotide Metabolism    8,9E-05 1,3E-04 1,5E-04 
One Carbon Metabolism    2,4E-02 3,4E-02 4,1E-02 
Oxidative Stress    1,5E-03 2,1E-03 6,6E-05 
Oxidative phosphorylation    2,2E-17 1,1E-16 3,3E-16 
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PI3K_AKT_NFKB pathway    5,4E-06 1,2E-05 3,4E-06 
PKC-SCP2    3,2E-04 2,5E-04 4,1E-04 
Proteasome Degradation    1,5E-11 4,8E-11 1,3E-10 
Regulation of Actin Cytoskeleton    2,0E-06 2,0E-07 2,4E-07 
Renin - Angiotensin System    6,0E-04 1,1E-04 4,8E-05 
Selenium metabolism Selenoproteins    2,3E-03 3,3E-03 4,0E-03 
Senescence and Autophagy    6,5E-08 2,9E-08 6,6E-08 
Signal Transduction of S1P    7,1E-03 9,9E-03 3,2E-03 
Signaling of Hepatocyte Growth Factor Receptor    1,0E-08 2,1E-08 4,2E-08 
T Cell Receptor Signaling Pathway    1,3E-09 7,3E-09 2,2E-07 
TCA Cycle    2,9E-05 5,0E-05 6,6E-05 
TGF Beta Signaling Pathway    9,3E-05 2,7E-06 4,6E-06 
TGF-beta Receptor Signaling Pathway    1,1E-19 2,2E-21 1,6E-19 
TNF-alpha NF-kB Signaling Pathway    6,4E-32 1,1E-32 2,2E-30 
TNF-alpha and mucus production in lung epythelium    3,2E-06 5,7E-06 7,7E-06 
The effect of Glucocorticoids on target gene 
expression    2,7E-03 3,6E-03 4,3E-03 
Toll-like receptor signaling pathway    3,1E-08 1,0E-07 5,3E-09 
Translation Factors    9,3E-11 2,5E-10 5,7E-10 
VEGF-receptor Signal Transduction    9,3E-04 5,4E-03 3,4E-04 
Wnt Signaling Pathway NetPath    3,6E-08 4,1E-08 5,7E-10 
Wnt Signaling Pathway and Pluripotency    2,2E-03 1,3E-03 1,2E-05 
estrogen signalling    4,5E-13 1,2E-13 4,0E-13 
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genetic alternations of lung cancer    3,5E-05 5,6E-05 7,5E-05 
mRNA processing    0,0E+00 2,4E-25 0,0E+00 
p38 MAPK Signaling Pathway (BioCarta)    2,5E-07 5,9E-06 4,3E-08 
p53 pathway    7,1E-07 4,3E-05 2,9E-06 
p53 signal pathway    2,1E-04 3,3E-04 4,6E-04 
Alanine and aspartate metabolism     5,6E-01 5,9E-01 4,1E-02 
Fatty Acid Biosynthesis     7,2E-02 8,9E-02 9,9E-03 
NLR proteins     1,3E-01 1,4E-01 2,9E-02 
Wnt Signaling Pathway      2,1E-01 1,2E-01 3,2E-02 
List of enriched Wikipathway signaling pathways from genes expressed in BNJ, BNH and 853 
Lewis rat RMG cells and their corresponding significance (adjusted P-values). 854 
855 
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Table 2. Signaling pathways enrichment in Janvier versus Lewis or Harlan rat primary 856 
retinal Müller glial cells.  857 
Signaling pathways JL JH HL 
TGF Beta Signaling Pathway     
Matrix Metalloproteinases     
Kit Receptor Signaling Pathway     
Type II interferon signaling (IFNG)     
MAPK Cascade     
p38 MAPK signaling pathway     
Signal Transduction of S1P      
Adipogenesis     
Endochondral Ossification     
Signaling of Hepatocyte Growth Factor Receptor      
Apoptosis     
Senescence and Autophagy     
p53 signal pathway     
Apoptosis Modulation by HSP70     
FAS pathway and Stress induction of HSP regulation     
Toll-like receptor signaling pathway     
B Cell Receptor Signaling Pathway     
IL-3 Signaling Pathway     
IL-4 Signaling Pathway     
IL-5 Signaling Pathway     
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IL-2 Signaling Pathway     
T Cell Receptor Signaling Pathway     
IL-6 Signaling Pathway     
IL-7 Signaling Pathway     
IL-9 Signaling Pathway   
Cytokines and Inflammatory Response     
G Protein Signaling Pathways     
Myometrial Relaxation and Contraction Pathways   
Small Ligand GPCRs   
GPCRs      
Regulation of Actin Cytoskeleton     
Striated Muscle Contraction   
G13 Signaling Pathway      
Cardiovascular Signaling     
Integrin-mediated cell adhesion   
Focal Adhesion     
EGFR1 Signaling Pathway     
CDKN1A-EGF-CREB     
Hypertrophy Model      
Calcium Regulation in the Cardiac Cell   
Insulin Signaling   
Osteoclast     
Delta-Notch Signaling Pathway      
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Wnt Signaling Pathway      
Oxidative Stress      
Id Signaling Pathway      
PI3K_AKT_NFKB pathway      
EBV LMP1 signaling     
TNF-alpha NF-kB Signaling Pathway      
EPO Receptor Signaling      
Renin - Angiotensin System      
Complement and Coagulation Cascades    
Glutathione metabolism    
Urea cycle and metabolism of amino groups      
Eicosanoid Synthesis     
JL: Signaling pathways enriched for genes differentially expressed between Janvier Brown 858 
Norway and Lewis rat RMGs. JH: Signaling pathways enriched for genes differentially 859 
expressed between Janvier and Harlan Brown Norway rat RMGs. HL: Signaling pathways 860 
enriched for genes differentially expressed between Harlan Brown Norway and Lewis rat 861 
RMGs.  The presented signaling pathways were selected based on significance (P-value ≤ 862 
0.05) unless stated otherwise.  863 
